Aras Emdadi

589 total citations
10 papers, 479 citations indexed

About

Aras Emdadi is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Aras Emdadi has authored 10 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Aras Emdadi's work include Melanoma and MAPK Pathways (5 papers), Cell death mechanisms and regulation (3 papers) and Synthesis and biological activity (3 papers). Aras Emdadi is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Cell death mechanisms and regulation (3 papers) and Synthesis and biological activity (3 papers). Aras Emdadi collaborates with scholars based in United States. Aras Emdadi's co-authors include Maurizio Pellecchia, John L. Stebbins, Li‐Hsing Chen, Jason Cellitti, Surya K. De, Megan Riel‐Mehan, Thomas Machleidt, Russell Dahl, Hongbin Yuan and Jesús Vázquez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Molecular Cancer Therapeutics.

In The Last Decade

Aras Emdadi

10 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aras Emdadi United States	10	359	139	103	71	51	10	479
Li‐Hsing Chen United States	11	343 1.0×	157 1.1×	106 1.0×	107 1.5×	47 0.9×	12	499
Jesús Vázquez Spain	10	265 0.7×	100 0.7×	54 0.5×	65 0.9×	29 0.6×	12	368
Lei Du‐Cuny United States	12	333 0.9×	85 0.6×	115 1.1×	51 0.7×	27 0.5×	14	467
Henrik Moebitz Switzerland	5	325 0.9×	105 0.8×	58 0.6×	119 1.7×	54 1.1×	8	441
Marc R. Arnone United States	7	474 1.3×	113 0.8×	122 1.2×	201 2.8×	70 1.4×	7	620
Joseph E. Myers United States	10	283 0.8×	89 0.6×	94 0.9×	59 0.8×	32 0.6×	12	488
Mary K. Joseph United States	8	367 1.0×	79 0.6×	102 1.0×	95 1.3×	19 0.4×	10	450
Min‐Wu Chao Taiwan	15	364 1.0×	86 0.6×	46 0.4×	149 2.1×	31 0.6×	26	492
Jeremy L. Yap United States	16	727 2.0×	256 1.8×	86 0.8×	183 2.6×	47 0.9×	22	867
Vivek Modi United States	9	494 1.4×	74 0.5×	156 1.5×	98 1.4×	40 0.8×	12	643

Countries citing papers authored by Aras Emdadi

Since Specialization

Citations

This map shows the geographic impact of Aras Emdadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aras Emdadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aras Emdadi more than expected).

Fields of papers citing papers by Aras Emdadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aras Emdadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aras Emdadi. The network helps show where Aras Emdadi may publish in the future.

Co-authorship network of co-authors of Aras Emdadi

This figure shows the co-authorship network connecting the top 25 collaborators of Aras Emdadi. A scholar is included among the top collaborators of Aras Emdadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aras Emdadi. Aras Emdadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Wei, Jun, Shinichi Kitada, Michele F. Rega, et al.. (2009). Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins. Molecular Cancer Therapeutics. 8(4). 904–913. 51 indexed citations

De, Surya K., John L. Stebbins, Li‐Hsing Chen, et al.. (2009). Synthesis and optimization of thiadiazole derivatives as a novel class of substrate competitive c-Jun N-terminal kinase inhibitors. Bioorganic & Medicinal Chemistry. 18(2). 590–596. 16 indexed citations

De, Surya K., Li‐Hsing Chen, John L. Stebbins, et al.. (2009). Discovery of 2-(5-nitrothiazol-2-ylthio)benzo[d]thiazoles as novel c-Jun N-terminal kinase inhibitors. Bioorganic & Medicinal Chemistry. 17(7). 2712–2717. 24 indexed citations

Johnson, Sherida L., Li‐Hsing Chen, Elisa Barile, et al.. (2009). Structure–activity relationship studies of a novel series of anthrax lethal factor inhibitors. Bioorganic & Medicinal Chemistry. 17(9). 3352–3368. 19 indexed citations

Wei, Jun, Shinichi Kitada, Michele F. Rega, et al.. (2009). Apogossypol Derivatives as Pan-Active Inhibitors of Antiapoptotic B-Cell Lymphoma/Leukemia-2 (Bcl-2) Family Proteins. Journal of Medicinal Chemistry. 52(14). 4511–4523. 45 indexed citations

De, Surya K., John L. Stebbins, Li‐Hsing Chen, et al.. (2009). Design, Synthesis, and Structure−Activity Relationship of Substrate Competitive, Selective, and in Vivo Active Triazole and Thiadiazole Inhibitors of the c-Jun N-Terminal Kinase. Journal of Medicinal Chemistry. 52(7). 1943–1952. 71 indexed citations

Stebbins, John L., Surya K. De, Thomas Machleidt, et al.. (2008). Identification of a new JNK inhibitor targeting the JNK-JIP interaction site. Proceedings of the National Academy of Sciences. 105(43). 16809–16813. 157 indexed citations

Huang, Jui-Wen, Ziming Zhang, Bainan Wu, et al.. (2008). Fragment-Based Design of Small Molecule X-Linked Inhibitor of Apoptosis Protein Inhibitors. Journal of Medicinal Chemistry. 51(22). 7111–7118. 43 indexed citations

Vázquez, Jesús, Surya K. De, Li‐Hsing Chen, et al.. (2008). Development of Paramagnetic Probes for Molecular Recognition Studies in Protein Kinases. Journal of Medicinal Chemistry. 51(12). 3460–3465. 28 indexed citations

10.

Stebbins, John L., Ziming Zhang, Jinhua Chen, et al.. (2007). Nuclear Magnetic Resonance Fragment-Based Identification of Novel FKBP12 Inhibitors. Journal of Medicinal Chemistry. 50(26). 6607–6617. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact